39 related articles for article (PubMed ID: 12837092)
1. Interaction of Zn(II)bleomycin-A
Follett SE; Ingersoll AD; Murray SA; Reilly TM; Lehmann TE
J Biol Inorg Chem; 2017 Oct; 22(7):1039-1054. PubMed ID: 28748309
[TBL] [Abstract][Full Text] [Related]
2. A Simple Colorimetric Assay of Bleomycin-Mediated DNA Cleavage Utilizing Double-Stranded DNA-Modified Gold Nanoparticles.
Akiyama Y; Kimura K; Komatsu S; Takarada T; Maeda M; Kikuchi A
Chembiochem; 2023 Jan; 24(1):e202200451. PubMed ID: 36156837
[TBL] [Abstract][Full Text] [Related]
3. Inverse Electron Demand Diels-Alder Reactions of Heterocyclic Azadienes, 1-Aza-1,3-Butadienes, Cyclopropenone Ketals, and Related Systems. A Retrospective.
Zhang J; Shukla V; Boger DL
J Org Chem; 2019 Aug; 84(15):9397-9445. PubMed ID: 31062977
[TBL] [Abstract][Full Text] [Related]
4. The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA.
Murray V; Chen JK; Chung LH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734689
[TBL] [Abstract][Full Text] [Related]
5. Engineered production and evaluation of 6'-deoxy-tallysomycin H-1 revealing new insights into the structure-activity relationship of the anticancer drug bleomycin.
Yang D; Hindra ; Dong LB; Crnovcic I; Shen B
J Antibiot (Tokyo); 2017 Aug; ():. PubMed ID: 28831149
[TBL] [Abstract][Full Text] [Related]
6. The disaccharide moiety of bleomycin facilitates uptake by cancer cells.
Schroeder BR; Ghare MI; Bhattacharya C; Paul R; Yu Z; Zaleski PA; Bozeman TC; Rishel MJ; Hecht SM
J Am Chem Soc; 2014 Oct; 136(39):13641-56. PubMed ID: 25184545
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bleomycin-mediated cleavage of a hairpin DNA library.
Segerman ZJ; Roy B; Hecht SM
Biochemistry; 2013 Aug; 52(31):5315-27. PubMed ID: 23834496
[TBL] [Abstract][Full Text] [Related]
8. A designer bleomycin with significantly improved DNA cleavage activity.
Huang SX; Feng Z; Wang L; Galm U; Wendt-Pienkowski E; Yang D; Tao M; Coughlin JM; Duan Y; Shen B
J Am Chem Soc; 2012 Aug; 134(32):13501-9. PubMed ID: 22831455
[TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of Actinoramides A-C, Highly Modified Peptides from a Marine Streptomyces sp.
Nam SJ; Kauffman CA; Jensen PR; Fenical W
Tetrahedron; 2011 Sep; 67(35):6707-6712. PubMed ID: 21857753
[TBL] [Abstract][Full Text] [Related]
10. Padanamides A and B, highly modified linear tetrapeptides produced in culture by a Streptomyces sp. isolated from a marine sediment.
Williams DE; Dalisay DS; Patrick BO; Matainaho T; Andrusiak K; Deshpande R; Myers CL; Piotrowski JS; Boone C; Yoshida M; Andersen RJ
Org Lett; 2011 Aug; 13(15):3936-9. PubMed ID: 21749075
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of tlmH in Streptoalloteichus hindustanus E465-94 ATCC 31158 unveiling new insight into tallysomycin biosynthesis and affording a novel bleomycin analog.
Tao M; Wang L; Wendt-Pienkowski E; Zhang N; Yang D; Galm U; Coughlin JM; Xu Z; Shen B
Mol Biosyst; 2010 Feb; 6(2):349-56. PubMed ID: 20094654
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of tlmK unveiling unstable carbinolamide intermediates in the tallysomycin biosynthetic pathway.
Wang L; Tao M; Wendt-Pienkoski E; Galm U; Coughlin JM; Shen B
J Biol Chem; 2009 Mar; 284(13):8256-64. PubMed ID: 19189972
[TBL] [Abstract][Full Text] [Related]
13. Glycopeptide antitumor antibiotic zorbamycin from Streptomyces flavoviridis ATCC 21892: strain improvement and structure elucidation.
Wang L; Yun BS; George NP; Wendt-Pienkowski E; Galm U; Oh TJ; Coughlin JM; Zhang G; Tao M; Shen B
J Nat Prod; 2007 Mar; 70(3):402-6. PubMed ID: 17311457
[TBL] [Abstract][Full Text] [Related]
14. Solid-phase synthesis of bleomycin group antibiotics. Construction of a 108-member deglycobleomycin library.
Leitheiser CJ; Smith KL; Rishel MJ; Hashimoto S; Konishi K; Thomas CJ; Li C; McCormick MM; Hecht SM
J Am Chem Soc; 2003 Jul; 125(27):8218-27. PubMed ID: 12837092
[TBL] [Abstract][Full Text] [Related]
15. Biochemical evaluation of a 108-member deglycobleomycin library: viability of a selection strategy for identifying bleomycin analogues with altered properties.
Ma Q; Xu Z; Schroeder BR; Sun W; Wei F; Hashimoto S; Konishi K; Leitheiser CJ; Hecht SM
J Am Chem Soc; 2007 Oct; 129(41):12439-52. PubMed ID: 17887752
[TBL] [Abstract][Full Text] [Related]
16. Solid-phase synthesis of deglycobleomycin and bleomycin.
Leitheiser CJ; Hecht SM
Curr Opin Drug Discov Devel; 2003 Nov; 6(6):827-37. PubMed ID: 14758754
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase synthesis of bleomycin group antibiotics. Elaboration of deglycobleomycin A(5).
Leitheiser CJ; Rishel MJ; Wu X; Hecht SM
Org Lett; 2000 Oct; 2(21):3397-9. PubMed ID: 11029220
[TBL] [Abstract][Full Text] [Related]
18. Deglycobleomycin A6 analogues modified in the methylvalerate moiety.
Cai X; Zaleski PA; Cagir A; Hecht SM
Bioorg Med Chem; 2011 Jun; 19(12):3831-44. PubMed ID: 21612932
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin: new perspectives on the mechanism of action.
Hecht SM
J Nat Prod; 2000 Jan; 63(1):158-68. PubMed ID: 10650103
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
